0000914190-15-000347.txt : 20150819
0000914190-15-000347.hdr.sgml : 20150819
20150819164205
ACCESSION NUMBER: 0000914190-15-000347
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150817
FILED AS OF DATE: 20150819
DATE AS OF CHANGE: 20150819
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kenny Kevin J.
CENTRAL INDEX KEY: 0001520400
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 151064512
MAIL ADDRESS:
STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC.
STREET 2: 1225 OLD HIGHWAY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER NAME:
FORMER CONFORMED NAME: Kenny Kevin J
DATE OF NAME CHANGE: 20110510
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-08-17
0001180145
Cardiovascular Systems Inc
CSII
0001520400
Kenny Kevin J.
1225 OLD HIGHWAY 8 NW
ST. PAUL
MN
55112
0
1
0
0
Chief Operating Officer
Common Stock
2015-08-17
4
S
0
1730
24.0105
D
119641
D
Common Stock
2015-08-18
4
S
0
2183
23.9838
D
117458
D
In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.97 to $24.07 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.82 to $24.10 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Amanda Schmall as Attorney-in-Fact for Kevin J. Kenny pursuant to Power of Attorney previously filed.
2015-08-19